Algeria Pharmaceuticals & Healthcare Report

Table of Contents

Chapter - Executive Summary

• Algeria Pharmaceuticals And Healthcare Industry SWOT

Chapter - Pharmaceutical Business Environment Ratings

• Table: Middle East And North Africa Pharmaceutical Business Environment Ratings for Q209
• Limits Of Potential Returns
• Risks To Realisation Of Returns

Chapter - Algeria - Market Summary

• Regulatory Regime
• Trade Agreements
• Intellectual Property Environment
• Intellectual Property Shortcomings
• Pricing And Reimbursement Regime

Chapter - Industry Trends And Developments

• Epidemiology
• Table Algeria - Top 10 Causes Of Death For All Ages (2002)
• Healthcare Sector
• Healthcare Sector Reforms
• Domestic Pharmaceutical Sector
• Recent Domestic Pharmaceutical Sector Developments
• Foreign Pharmaceutical Sector
• Recent Foreign Pharmaceutical Sector Developments
• Pharmaceutical Wholesale
• Pharmaceutical Retail
• Biotechnology And Research
• Medical Devices

Chapter - Industry Forecast Scenario

• Overall Market Forecast
• Table: Algeria - Drug Expenditure Indicators, Historical Data and Forecasts
• Key Growth Factors - Industry
• Table: Algeria - Health Expenditure Indicators, Historical Data and Forecasts
• Key Growth Factors - Macroeconomic Chapter
• Table: Algeria- Economic Activity
• Prescription Market Forecast
• Table: Algeria - Prescription Market Indicators, Historical Data and Forecasts (DZDmn unless otherwise stated)
• Patented Drug Market Forecast
• Table: Algeria - Patented Drug Market Indicators, Historical Data and Forecasts
• Generics Market Forecasts
• Table: Algeria - Generics Market Indicators, Historical Data and Forecasts
• OTC Market Forecast
• Table: Algeria - OTC Market Indicators, Historical Data and Forecasts (DZDmn unless otherwise stated)
• Pharmaceutical Trade Forecasts
• Table: Algeria - Pharmaceutical Trade Indicators, Historical Data and Forecasts (US$mn)
• Other Healthcare Data Forecasts
• Table: Algeria - Other Healthcare Indicators, Historical Data And Forecasts
• Key Risks To BMI' s Forecast Scenario
• Key Risks To BMI' s Forecast Scenario

Chapter - Competitive Landscape

• Table Leading Pharmaceutical Companies In Algeria

Chapter - Company Profiles

• Leading Multinationals
• Sanofi-Aventis
• GlaxoSmithKline (GSK)
• Pfizer
• Novartis
• Merck & Co
• Leading Indigenous Manufacturer
• Groupe Saidal

Chapter - Country Snapshot: Algeria Demographic Data

• Section 1: Population
• Table: Demographic Indicators, 2005-2030
• Table: Rural/Urban Breakdown, 2005-2030
• Section 2: Education And Healthcare
• Table: Education Levels, 2002-2025
• Table: Healthcare - Vital Statistics, 2005-2030
• Section 3: Labour Market And Spending Power
• Table: Employment Indicators, 2001-2006
• Table: Consumer Expenditure, 2000-2012 (US$)

Chapter - BMI Forecast Modelling

• How We Generate Our Pharmaceutical Industry Forecasts
• Pharmaceutical Business Environment Ratings Methodology
• Ratings Overview
• Table: Pharmaceutical Business Environment Indicators
• Weighting
• Table: Weighting Of Components
• Sources